Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» MannKind asks for approval of Afrezza 2 years after FDA asked for more studies; shares rise
MannKind asks for approval of Afrezza 2 years after FDA asked for more studies; shares rise
MannKind asks for approval of Afrezza 2 years after FDA asked for more studies; shares rise
Submitted by
admin
on October 14, 2013 - 9:32am
Source:
Yahoo/AP
News Tags:
inhaled insulin
MannKind
diabetes
Afrezza
FDA
Headline:
MannKind asks for approval of Afrezza 2 years after FDA asked for more studies; shares rise
Do Not Allow Advertisers to Use My Personal information
